One of the core limitations of animal models for AD is that these models are often limited to inducing the central nervous system components of AD (such as amyloid-β plaques, hyperphosphorylated tau proteins, and neurofibrillary tangles), but these are often absent of multiple naturally occurring chronic co-morbidities. Here, MAPT is linked to Alzheimer disease.